Today is definitely the right day for a ganja break….
CA-Sen: President Obama was out in California doing not one but three separate fundraising events for Sen. Barbara Boxer. The fundraisers are expected to bring in between $3 and $3.5 million, split between the DNC and the Boxer campaign. But I can’t imagine it will be an even split, seeing as donation caps for party committees are more than ten times greater than for campaigns.
DE-Sen: WTF? Can someone please explain to me why, of all people, Chris Van Hollen – the chair of the DCCC – is helping to fluff Republican Rep. Mike Castle’s bipartisan cred? CVH is co-sponsoring legislation with Castle which is aimed at “responding” to the Supreme Court’s Citizens United ruling. The merits of the issue aside, why on earth give a gift like this to Castle?
PA-Sen: The primary is just a month away – so Joe Sestak finally has to blow his cash hoard on a crunch-time push against Arlen Specter, right? PoliticsPA says that their sources are confirming Sestak will at last go on the air with TV ads today, but doesn’t have any details on the size or breadth of the buy.
MI-01: Dem state Sen. Mike Prusi, who had been weighing a bid to succeed retiring Rep. Bart Stupak, says he won’t run. There are still several Dems in the mix, though.
Chicago-Mayor: After denying it for quite some time, Rahm Emanuel finally admitted to Charlie Rose that he would like to be mayor of Chicago some day – but that he wouldn’t challenge his “dear friend” Richard Daley.
Polling: Nate Silver points up an interesting issue with Rasmussen’s “House Effect.” Rasmussen defenders often argue that the firm’s likely voter screen produces more-Republican results because conservatives are more fired up this cycle. The problem with that claim is that Rasmussen does release one set of numbers that cover all adults and are not screened in any way: their monthly partisan ID tracker. And on this measure, too, Ras is six points redder than average. Nate offers a few guesses as to why Ras leans this way even without any screening.